We recently published 10 Stocks Left Behind Amid Wall Street Cheer. Perrigo Company plc (NYSE:PRGO) is one of the ...

Perrigo (PRGO) on Wednesday said that it is initiating a strategic review of its infant formula business, which will assess a ...

Despite the earnings beat, Perrigo lowered its full-year 2025 outlook, now expecting adjusted earnings of $2.70 to $2.80 per share, below the previous analyst consensus of $2.98. The company also ...

Q3 2025 Management View CEO Patrick Lockwood-Taylor reported that "Perrigo has delivered sustained share gains and advanced key initiatives under our Three-S plan to Stabilize, Streamline and to ...

Perrigo is initiating a review of its infant formula business, citing an external environment that has made the segment's fit with the company's over-the-counter businesses less strategic, the company ...

Formulas for toddlers are a burgeoning business in the United States: Sales of the drinks more than doubled in recent years as companies convinced parents that their little ones needed the liquid ...

Perrigo PRGO reported adjusted earnings of 80 cents per share in the third quarter of 2025, beating the Zacks Consensus ...

Net sales show the true revenue your business makes from selling products or services, after subtracting returns, allowances and discounts. To find net sales, begin with your total sales and deduct ...

ByHeart, a manufacturer of organic baby formula, recalled all of its products sold nationwide Tuesday, days after some ...

Perrigo said on Wednesday it has initiated a strategic review of its infant formula business as the consumer health company ...